Shuyu Zhang

Shuyu Zhang

Auto-generated profile, based on publicly available information

Shuyu Zhang

Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Blacksburg, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
SZShuyu Zhang
Shuyu Zhang
Anne StaplesAnne Staples
Anne Staples
Diabetes currently affects approximately 500 million people worldwide and is one of the most common causes of mortality in the United States. To diagnose and monitor diabetes, finger-prick blood glucose testing has long been used as the clinical gold standard. For diabetes treatment, insulin is typically delivered subcutaneously through cannula-based syringes, pens, or pumps in almost all type 1 diabetic (T1D) patients and some type 2 diabetic (T2D) patients. These painful, invasive approaches can cause non-adherence to glucose testing and insulin therapy. To address these problems, researchers have developed miniaturized blood glucose testing devices as well as microfluidic platforms for non-invasive glucose testing through other body fluids. In addition, glycated hemoglobin (HbA1c), insulin levels, and cellular biomechanics-related metrics have also been considered for microfluidic-based diabetes diagnosis. For the treatment of diabetes, insulin has been delivered transdermally through microdevices, mostly through microneedle array-based, minimally invasive injections. Researchers have also developed microfluidic platforms for oral, intraperitoneal, and inhalation-based delivery of insulin. For T2D patients, metformin, glucagon-like peptide 1 (GLP-1), and GLP-1 receptor agonists have also been delivered using microfluidic technologies. Thus far, clinical studies have been widely performed on microfluidic-based diabetes monitoring, especially glucose sensing, yet technologies for the delivery of insulin and other drugs to diabetic patients with microfluidics are still mostly in the preclinical stage. This article provides a concise review of the role of microfluidic devices in the diagnosis and monitoring of diabetes, as well as the delivery of pharmaceuticals to treat diabetes using microfluidic technologies in the recent literature. Graphical abstract

21 August 2025 in npj Materials Degradation
Verified
Journal Article
Open access
PDF file
SZShuyu Zhang
Shuyu Zhang
Anne StaplesAnne Staples
Anne Staples
Polydimethylsiloxane (PDMS) is a synthetic elastomer widely used in biomedical and industrial applications. Despite its widespread use, the natural evolution of its mechanical and surface properties over time remains poorly understood. In this study, we fabricated PDMS samples with base-to-curing agent mixing ratios from 5:1 to 30:1 and aged them for up to 8 weeks under six non-harsh conditions at room temperature. Contact angle measurements revealed increasing hydrophobicity with aging, with maximum increases up to 16.5°. Mechanical testing showed up to 130% increases in Young’s modulus and 60% changes in flexibility after 5 weeks. Storage in mineral oil best preserved surface hydrophilicity, while storage in water best maintained mechanical integrity. These results provide a framework for optimizing PDMS storage conditions in microfluidic and biomedical device applications.

1 June 2024 in AIP Advances
Verified
Journal Article
Open access
PDF file
SZShuyu Zhang
Shuyu Zhang
JSJenna Sims
Jenna Sims
IMIsabelle Mehochko
Isabelle Mehochko
RZRyan Zolovick
Ryan Zolovick
TKTyler Kwak
Tyler Kwak
Anne StaplesAnne Staples
Anne Staples
The delivery of insulin to diabetic patients remains a challenge due to the limitations of current insulin delivery paradigms, including painful cannula insertion, potential infections, interference with activity, embarrassment, and sometimes cost. To address this problem, we designed and fabricated nine prototypes of stereolithographic 3D-printed microneedle arrays (MNAs) appropriate for the minimally invasive delivery of insulin. We characterized their transdermal penetration performance by delivering fluid at a constant rate to porcine skin through these MNAs. Moreover, we characterized the force required for these MNAs to puncture porcine skin using a mechanical testing apparatus. We developed an improved method of mechanical testing for the MNAs against porcine skin by incorporating an imitation soft tissue layer under the skin and compared the MNA results with those using a single microneedle and a hypodermic needle. In addition, we investigated the mechanical flexural strength of the MNAs by performing a flexural failure load test on them. We confirmed that the prototype MNAs are mechanically robust and do not fracture during skin penetration, setting the stage for future trials in vitro and in vivo. The final, optimized designs are freely available in stereolithography (STL) file format.

21 April 2026 in Advanced NanoBiomed Research
Verified
Journal Article
Open access
SZShuyu Zhang
Shuyu Zhang
Anne StaplesAnne Staples
Anne Staples
Biomaterials, generally defined as materials that interact with biological systems, are ubiquitous in the field of biomedical engineering. Biomaterials can undergo natural aging, in which changes in material properties occur in near‐ambient or near‐physiological environments without external acceleration. This can be either beneficial or harmful to the material or the tissue that interacts with the material. Such natural aging depends on material composition, temperature, pH, storage media composition, sterilization, and numerous other factors. This review focuses on studies investigating the natural aging of polymers, metals, ceramics, and nanomaterials, and their impact on material characteristics and functions as biomaterials.